ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-zeolite to prevent Chemotherapy-Induced Side Effects, in particular, Peripheral Neuropathy.

Molecules · 2020 · PMC7288011 · PMID 32414185

Europe PMC DOI

hedged sentence

0.5600

closest p · 11.2× alpha

0.5600

boldest claim

The sentences

did not reach statistical significancep = 0.56not close (p > 0.1)

After six months from the last cycle of chemotherapy, the incidence of the CIPN (Neurography 3) in the placebo group was higher than that in the PMA-zeolite group (70.6% and 64.3%, respectively), although this difference did not reach statistical significance ( p = 0.56) (response rate 64%).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.